External Quality Assessment Services For Cancer Diagnostics C.I.C.
10585826
Healthy
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 26/01/2017
SCIENTIST
BRITISH · ENGLAND · Age 55
Also on 2 other boards
director · Since 01/02/2017
BIOMEDICAL SCIENTIST
BRITISH · UNITED KINGDOM · Age 55
Also on 1 other board
director · Since 21/11/2018
DIRECTOR
BRITISH · ENGLAND · Age 60
Also on 15 other boards
Persons with Significant Control
Former PSCs
Mr Keith David Miller
Ceased 07/02/2018
Mr Andrew Roy Dodson
Ceased 07/02/2018
Ms Suzanne Clare Parry
Ceased 07/02/2018
CompanyRankvs 10552+ SIC 96090 peers79
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Turnover
£1.7M
Annual revenue
Net Worth
£925k
Balance sheet strength
Cash
£550k
Cash in the bank
Profit Before Tax
-£187k
Bottom line earnings
Net Current Assets
£564k
Working capital
Current Assets
£1.5M
Current Liabilities
£977k
Fixed Assets
£445k
Debtors
£967k
Cost of Sales
£440k
Gross Profit
£1.3M
Admin Expenses
£1.5M
Operating Profit
-£189k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.58 | -£170k |
| 2024 | 4.12 | +£14k |
| 2023 | 2.00 | +£200k |
| 2022 | 1.59 | +£62k |
| 2021 | 3.42 | +£302k |
| 2020 | 1.68 | +£185k |
| 2019 | 1.47 | — |
Derived from filed accounts. Not audited figures.